Found: 20
Select item for more details and to access through your institution.
Targeting NOX2 and glycolytic metabolism as a therapeutic strategy in acute myeloid leukaemia.
- Published in:
- 2024
- By:
- Publication type:
- Letter
SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1097-z
- By:
- Publication type:
- Article
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 1, p. 93, doi. 10.1111/bjh.16013
- By:
- Publication type:
- Article
Azacitidine improves outcome in higher‐risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 3, p. 350, doi. 10.1111/bjh.15190
- By:
- Publication type:
- Article
Improved benefit of continuing luspatercept therapy: sub-analysis of patients with lower-risk MDS in the MEDALIST study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 2, p. 311, doi. 10.1007/s00277-022-05071-8
- By:
- Publication type:
- Article
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation.
- Published in:
- 2019
- By:
- Publication type:
- Journal Article
Prognostic impact of the number of methylated genes in myelodysplastic syndromes and acute myeloid leukemias treated with azacytidine.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 11, p. 1543, doi. 10.1007/s00277-013-1799-9
- By:
- Publication type:
- Article
Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8.
- Published in:
- Cancers, 2023, v. 15, n. 15, p. 3822, doi. 10.3390/cancers15153822
- By:
- Publication type:
- Article
Chronic Graft-Versus-Host Disease: Pathogenesis and Clinical Management.
- Published in:
- Drugs, 2006, v. 66, n. 8, p. 1041
- By:
- Publication type:
- Article
Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221142137
- By:
- Publication type:
- Article
The Role of Hypomethylating Agents (Hma) in Early Myeloid Relapses After Allogenic Hematopoietic Stem Cell Transplant (HSCT).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S84, doi. 10.1016/j.clml.2016.07.119
- By:
- Publication type:
- Article
Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164370
- By:
- Publication type:
- Article
Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation.
- Published in:
- Transfusion, 2012, v. 52, n. 5, p. 1086, doi. 10.1111/j.1537-2995.2011.03400.x
- By:
- Publication type:
- Article
Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.
- Published in:
- Transfusion, 2009, v. 49, n. 9, p. 1901, doi. 10.1111/j.1537-2995.2009.02226.x
- By:
- Publication type:
- Article
Single nucleotide polymorphism array karyotyping: A diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing.
- Published in:
- Genes, Chromosomes & Cancer, 2013, v. 52, n. 12, p. 1167, doi. 10.1002/gcc.22112
- By:
- Publication type:
- Article
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. E534, doi. 10.1002/ajh.24813
- By:
- Publication type:
- Article
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 614, doi. 10.1002/ajh.24732
- By:
- Publication type:
- Article
Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 4, p. 290, doi. 10.1002/ajh.21613
- By:
- Publication type:
- Article
Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 3, p. 149, doi. 10.1002/ajh.21340
- By:
- Publication type:
- Article
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft- versus-host disease after allogeneic transplantation.
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 3, p. 394, doi. 10.1111/j.1365-2141.2005.05614.x
- By:
- Publication type:
- Article